Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 6, 2015, Pages 1651-1654

  Brown, Sheena D ^a   Brown, Lou Ann ^a,b   Stephenson, Susan ^a   Dodds, Jennifer C ^a   Douglas, Shaneka L ^a   Qu, Hongyan ^a   Fitzpatrick, Anne M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE; METHACHOLINE; SALBUTAMOL; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CHUK PROTEIN, HUMAN; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF-KAPPAB INHIBITOR ALPHA; NFKB1 PROTEIN, HUMAN; TRIAMCINOLONE;

ADOLESCENT; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HUMAN; LETTER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ASTHMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYMPTOM; CASE CONTROL STUDY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; PATHOLOGY; PERSONALIZED MEDICINE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ASTHMA; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; MALE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHENOTYPE; PRECISION MEDICINE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TRIAMCINOLONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84951567543     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.08.054     Document Type: Article

References (9)

1. M.A. Berry, B. Hargadon, M. Shelley, D. Parker, D.E. Shaw, R.H. Green, and et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma N Engl J Med 354 2006 697 708
2. S.T. Holgate, M. Noonan, P. Chanez, W. Busse, L. Dupont, I. Pavord, and et al. Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial Eur Respir J 37 2011 1352 1359
3. R. Gagliardo, P. Chanez, M. Profita, A. Bonanno, G.D. Albano, A.M. Montalbano, and et al. IkappaB kinase-driven nuclear factor-kappaB activation in patients with asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 128 2011 635 645 e1-2
4. P.H. Howarth, K.S. Babu, H.S. Arshad, L. Lau, M. Buckley, W. McConnell, and et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma Thorax 60 2005 1012 1018
5. S.J. Szefler, J.F. Chmiel, A.M. Fitzpatrick, G. Giacoia, T.P. Green, D.J. Jackson, and et al. Asthma across the ages: knowledge gaps in childhood asthma J Allergy Clin Immunol 133 2014 3 14
6. E.F. Juniper, J. Bousquet, L. Abetz, E.D. Bateman, and G. Committee Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire Respir Med 100 2006 616 621
7. E. National Asthma, and P. Prevention Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 Suppl 2007 S94 S138
8. A.M. Fitzpatrick, S.T. Stephenson, G.R. Hadley, L. Burwell, M. Penugonda, D.M. Simon, and et al. Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2 J Allergy Clin Immunol 127 2011 1604 1611
9. E. Goleva, L.P. Jackson, M. Gleason, and D.Y. Leung Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients J Allergy Clin Immunol 129 2012 687 693.e1